English
简体中文
Total: £ 56.28
Published Date: 2025-03-25 | Pages: 83 | Tables: 88 | Pharma & Healthcare
The global market for Stem Cell Therapy for Osteoarthritis was valued at US$ 42 million in the year 2024 and is projected to reach a revised size of US$ 256 million by 2031, growing at a CAGR of 29.9% during the forecast period.
OA is the most common degenerative joint disease. Its initial symptoms include loss of articular cartilage followed by progressive to joint stiffness, swelling, pain, and loss of mobility. The prevalence rate of OA is extremely high, affecting more than 250 million people worldwide. With increases in the aging and obese populations, the prevalence of OA is predicted to increase to 67 million by 2030. Hence, an effective and safe OA treatment is urgently required.
Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called daughter cells. These daughter cells either become new stem cells (self-renewal) or become specialized cells (differentiation) with a more specific function, such as blood cells, brain cells, heart muscle cells or bone cells. No other cell in the body has the natural ability to generate new cell types.
The key players of Stem Cell Therapy for Osteoarthritis include Medipost, Theracell Advanced Biotechnology, Nature Cell and Stempeutics. The top 2 manufacturers hold approximately 84% of the global market share.
In terms of product type, Fat Cell is the largest segment, with a share of 94%. And in terms of application, Primary Osteoarthritis has a share about 91 percent.
This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy for Osteoarthritis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy for Osteoarthritis.
The Stem Cell Therapy for Osteoarthritis market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Stem Cell Therapy for Osteoarthritis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Stem Cell Therapy for Osteoarthritis companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medipost
Theracell Advanced Biotechnology
Nature Cell
Stempeutics
Regeneus
Xintela AB
Cells for Cells
CellTex Therapeutics
UCI Health
Magellan
AbelZeta Pharma
Segment by Type
Fat Cell
Bone Marrow Cell
Others
Segment by Application
Primary Osteoarthritis
Secondary Osteoarthritis
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Stem Cell Therapy for Osteoarthritis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Fat Cell
1.2.3 Bone Marrow Cell
1.2.4 Others
1.3 Market by Application
1.3.1 Global Stem Cell Therapy for Osteoarthritis Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Primary Osteoarthritis
1.3.3 Secondary Osteoarthritis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Stem Cell Therapy for Osteoarthritis Market Perspective (2020-2031)
2.2 Global Stem Cell Therapy for Osteoarthritis Growth Trends by Region
2.2.1 Global Stem Cell Therapy for Osteoarthritis Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Stem Cell Therapy for Osteoarthritis Historic Market Size by Region (2020-2025)
2.2.3 Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2026-2031)
2.3 Stem Cell Therapy for Osteoarthritis Market Dynamics
2.3.1 Stem Cell Therapy for Osteoarthritis Industry Trends
2.3.2 Stem Cell Therapy for Osteoarthritis Market Drivers
2.3.3 Stem Cell Therapy for Osteoarthritis Market Challenges
2.3.4 Stem Cell Therapy for Osteoarthritis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue
3.1.1 Global Top Stem Cell Therapy for Osteoarthritis Players by Revenue (2020-2025)
3.1.2 Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Players (2020-2025)
3.2 Global Stem Cell Therapy for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Stem Cell Therapy for Osteoarthritis Revenue
3.4 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio
3.4.1 Global Stem Cell Therapy for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Stem Cell Therapy for Osteoarthritis Revenue in 2024
3.5 Global Key Players of Stem Cell Therapy for Osteoarthritis Head office and Area Served
3.6 Global Key Players of Stem Cell Therapy for Osteoarthritis, Product and Application
3.7 Global Key Players of Stem Cell Therapy for Osteoarthritis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Stem Cell Therapy for Osteoarthritis Breakdown Data by Type
4.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Type (2020-2025)
4.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2026-2031)
5 Stem Cell Therapy for Osteoarthritis Breakdown Data by Application
5.1 Global Stem Cell Therapy for Osteoarthritis Historic Market Size by Application (2020-2025)
5.2 Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Stem Cell Therapy for Osteoarthritis Market Size (2020-2031)
6.2 North America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025)
6.4 North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Stem Cell Therapy for Osteoarthritis Market Size (2020-2031)
7.2 Europe Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025)
7.4 Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size (2020-2031)
8.2 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2020-2025)
8.4 Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Stem Cell Therapy for Osteoarthritis Market Size (2020-2031)
9.2 Latin America Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025)
9.4 Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size (2020-2031)
10.2 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025)
10.4 Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medipost
11.1.1 Medipost Company Details
11.1.2 Medipost Business Overview
11.1.3 Medipost Stem Cell Therapy for Osteoarthritis Introduction
11.1.4 Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.1.5 Medipost Recent Development
11.2 Theracell Advanced Biotechnology
11.2.1 Theracell Advanced Biotechnology Company Details
11.2.2 Theracell Advanced Biotechnology Business Overview
11.2.3 Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Introduction
11.2.4 Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.2.5 Theracell Advanced Biotechnology Recent Development
11.3 Nature Cell
11.3.1 Nature Cell Company Details
11.3.2 Nature Cell Business Overview
11.3.3 Nature Cell Stem Cell Therapy for Osteoarthritis Introduction
11.3.4 Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.3.5 Nature Cell Recent Development
11.4 Stempeutics
11.4.1 Stempeutics Company Details
11.4.2 Stempeutics Business Overview
11.4.3 Stempeutics Stem Cell Therapy for Osteoarthritis Introduction
11.4.4 Stempeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.4.5 Stempeutics Recent Development
11.5 Regeneus
11.5.1 Regeneus Company Details
11.5.2 Regeneus Business Overview
11.5.3 Regeneus Stem Cell Therapy for Osteoarthritis Introduction
11.5.4 Regeneus Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.5.5 Regeneus Recent Development
11.6 Xintela AB
11.6.1 Xintela AB Company Details
11.6.2 Xintela AB Business Overview
11.6.3 Xintela AB Stem Cell Therapy for Osteoarthritis Introduction
11.6.4 Xintela AB Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.6.5 Xintela AB Recent Development
11.7 Cells for Cells
11.7.1 Cells for Cells Company Details
11.7.2 Cells for Cells Business Overview
11.7.3 Cells for Cells Stem Cell Therapy for Osteoarthritis Introduction
11.7.4 Cells for Cells Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.7.5 Cells for Cells Recent Development
11.8 CellTex Therapeutics
11.8.1 CellTex Therapeutics Company Details
11.8.2 CellTex Therapeutics Business Overview
11.8.3 CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Introduction
11.8.4 CellTex Therapeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.8.5 CellTex Therapeutics Recent Development
11.9 UCI Health
11.9.1 UCI Health Company Details
11.9.2 UCI Health Business Overview
11.9.3 UCI Health Stem Cell Therapy for Osteoarthritis Introduction
11.9.4 UCI Health Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.9.5 UCI Health Recent Development
11.10 Magellan
11.10.1 Magellan Company Details
11.10.2 Magellan Business Overview
11.10.3 Magellan Stem Cell Therapy for Osteoarthritis Introduction
11.10.4 Magellan Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.10.5 Magellan Recent Development
11.11 AbelZeta Pharma
11.11.1 AbelZeta Pharma Company Details
11.11.2 AbelZeta Pharma Business Overview
11.11.3 AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Introduction
11.11.4 AbelZeta Pharma Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
11.11.5 AbelZeta Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Fat Cell
Table 3. Key Players of Bone Marrow Cell
Table 4. Key Players of Others
Table 5. Global Stem Cell Therapy for Osteoarthritis Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Stem Cell Therapy for Osteoarthritis Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2020-2025)
Table 9. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Stem Cell Therapy for Osteoarthritis Market Share by Region (2026-2031)
Table 11. Stem Cell Therapy for Osteoarthritis Market Trends
Table 12. Stem Cell Therapy for Osteoarthritis Market Drivers
Table 13. Stem Cell Therapy for Osteoarthritis Market Challenges
Table 14. Stem Cell Therapy for Osteoarthritis Market Restraints
Table 15. Global Stem Cell Therapy for Osteoarthritis Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Stem Cell Therapy for Osteoarthritis Market Share by Players (2020-2025)
Table 17. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2024)
Table 18. Ranking of Global Top Stem Cell Therapy for Osteoarthritis Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Stem Cell Therapy for Osteoarthritis, Headquarters and Area Served
Table 21. Global Key Players of Stem Cell Therapy for Osteoarthritis, Product and Application
Table 22. Global Key Players of Stem Cell Therapy for Osteoarthritis, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Stem Cell Therapy for Osteoarthritis Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2020-2025)
Table 26. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Type (2026-2031)
Table 28. Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2020-2025)
Table 30. Global Stem Cell Therapy for Osteoarthritis Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Stem Cell Therapy for Osteoarthritis Revenue Market Share by Application (2026-2031)
Table 32. North America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size by Country (2026-2031) & (US$ Million)
Table 47. Medipost Company Details
Table 48. Medipost Business Overview
Table 49. Medipost Stem Cell Therapy for Osteoarthritis Product
Table 50. Medipost Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 51. Medipost Recent Development
Table 52. Theracell Advanced Biotechnology Company Details
Table 53. Theracell Advanced Biotechnology Business Overview
Table 54. Theracell Advanced Biotechnology Stem Cell Therapy for Osteoarthritis Product
Table 55. Theracell Advanced Biotechnology Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 56. Theracell Advanced Biotechnology Recent Development
Table 57. Nature Cell Company Details
Table 58. Nature Cell Business Overview
Table 59. Nature Cell Stem Cell Therapy for Osteoarthritis Product
Table 60. Nature Cell Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 61. Nature Cell Recent Development
Table 62. Stempeutics Company Details
Table 63. Stempeutics Business Overview
Table 64. Stempeutics Stem Cell Therapy for Osteoarthritis Product
Table 65. Stempeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 66. Stempeutics Recent Development
Table 67. Regeneus Company Details
Table 68. Regeneus Business Overview
Table 69. Regeneus Stem Cell Therapy for Osteoarthritis Product
Table 70. Regeneus Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 71. Regeneus Recent Development
Table 72. Xintela AB Company Details
Table 73. Xintela AB Business Overview
Table 74. Xintela AB Stem Cell Therapy for Osteoarthritis Product
Table 75. Xintela AB Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 76. Xintela AB Recent Development
Table 77. Cells for Cells Company Details
Table 78. Cells for Cells Business Overview
Table 79. Cells for Cells Stem Cell Therapy for Osteoarthritis Product
Table 80. Cells for Cells Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 81. Cells for Cells Recent Development
Table 82. CellTex Therapeutics Company Details
Table 83. CellTex Therapeutics Business Overview
Table 84. CellTex Therapeutics Stem Cell Therapy for Osteoarthritis Product
Table 85. CellTex Therapeutics Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 86. CellTex Therapeutics Recent Development
Table 87. UCI Health Company Details
Table 88. UCI Health Business Overview
Table 89. UCI Health Stem Cell Therapy for Osteoarthritis Product
Table 90. UCI Health Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 91. UCI Health Recent Development
Table 92. Magellan Company Details
Table 93. Magellan Business Overview
Table 94. Magellan Stem Cell Therapy for Osteoarthritis Product
Table 95. Magellan Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 96. Magellan Recent Development
Table 97. AbelZeta Pharma Company Details
Table 98. AbelZeta Pharma Business Overview
Table 99. AbelZeta Pharma Stem Cell Therapy for Osteoarthritis Product
Table 100. AbelZeta Pharma Revenue in Stem Cell Therapy for Osteoarthritis Business (2020-2025) & (US$ Million)
Table 101. AbelZeta Pharma Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Stem Cell Therapy for Osteoarthritis Picture
Figure 2. Global Stem Cell Therapy for Osteoarthritis Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Stem Cell Therapy for Osteoarthritis Market Share by Type: 2024 VS 2031
Figure 4. Fat Cell Features
Figure 5. Bone Marrow Cell Features
Figure 6. Others Features
Figure 7. Global Stem Cell Therapy for Osteoarthritis Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Stem Cell Therapy for Osteoarthritis Market Share by Application: 2024 VS 2031
Figure 9. Primary Osteoarthritis Case Studies
Figure 10. Secondary Osteoarthritis Case Studies
Figure 11. Stem Cell Therapy for Osteoarthritis Report Years Considered
Figure 12. Global Stem Cell Therapy for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Stem Cell Therapy for Osteoarthritis Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Stem Cell Therapy for Osteoarthritis Market Share by Region: 2024 VS 2031
Figure 15. Global Stem Cell Therapy for Osteoarthritis Market Share by Players in 2024
Figure 16. Global Top Stem Cell Therapy for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy for Osteoarthritis as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Stem Cell Therapy for Osteoarthritis Revenue in 2024
Figure 18. North America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Stem Cell Therapy for Osteoarthritis Market Share by Country (2020-2031)
Figure 20. United States Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Stem Cell Therapy for Osteoarthritis Market Share by Country (2020-2031)
Figure 24. Germany Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Stem Cell Therapy for Osteoarthritis Market Share by Region (2020-2031)
Figure 32. China Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Stem Cell Therapy for Osteoarthritis Market Share by Country (2020-2031)
Figure 40. Mexico Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Stem Cell Therapy for Osteoarthritis Market Share by Country (2020-2031)
Figure 44. Turkey Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Stem Cell Therapy for Osteoarthritis Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Medipost Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 48. Theracell Advanced Biotechnology Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 49. Nature Cell Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 50. Stempeutics Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 51. Regeneus Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 52. Xintela AB Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 53. Cells for Cells Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 54. CellTex Therapeutics Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 55. UCI Health Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 56. Magellan Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 57. AbelZeta Pharma Revenue Growth Rate in Stem Cell Therapy for Osteoarthritis Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
